ID

21504

Description

Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00416312

Lien

https://clinicaltrials.gov/show/NCT00416312

Mots-clés

Versions (1)
  1. 25/04/2017 25/04/2017 -
Téléchargé le

25 avril 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Lymphoma NCT00416312

Anglais

Eligibility Lymphoma NCT00416312

1 Formulaires  
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00416312
Criteria
Description

Criteria

diagnosis of non-hodgkin's lymphoma
Description

Lymphoma, Non-Hodgkin

Type de données

boolean

Alias
UMLS CUI [1]
C0024305
measurable disease by ct scan or nuclear medicine imaging
Description

Measurable Disease X-Ray Computed Tomography | Measurable Disease Radionuclide Imaging

Type de données

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C0040405
UMLS CUI [2,1]
C1513041
UMLS CUI [2,2]
C0034606
eligible, by standard of care criteria, for iodine i 131 tositumomab or yttrium y 90 ibritumomab tiuxetan treatment
Description

Standard of Care criteria | Iodine-131 [I-131] tositumomab | yttrium-90-ibritumomab tiuxetan

Type de données

boolean

Alias
UMLS CUI [1,1]
C2936643
UMLS CUI [1,2]
C0243161
UMLS CUI [2]
C1260363
UMLS CUI [3]
C1134535
patient characteristics:
Description

Client Characteristics

Type de données

boolean

Alias
UMLS CUI [1]
C0815172
no other malignancy within the past 3 years except basal cell carcinoma or squamous cell carcinoma of the skin or in situ carcinoma of the cervix
Description

Malignant Neoplasms Absent | Basal cell carcinoma | Squamous cell carcinoma of skin | Carcinoma in situ of uterine cervix

Type de données

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0332197
UMLS CUI [2]
C0007117
UMLS CUI [3]
C0553723
UMLS CUI [4]
C0851140
not pregnant or nursing
Description

Pregnancy Absent | Breast Feeding Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0006147
UMLS CUI [2,2]
C0332197
fertile patients must use effective contraception
Description

Fertility Contraceptive methods

Type de données

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
no alcoholism or drug abuse within the past 2 years
Description

Chronic Alcoholic Intoxication Absent | Drug abuse Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0001973
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0013146
UMLS CUI [2,2]
C0332197
no severe emotional, behavioral, or psychiatric problems that would limit study compliance
Description

Emotional problems Severe Absent | Behaviorial problem Severe Absent | Psychiatric problem Severe Absent | Mental problem Protocol Compliance Limited

Type de données

boolean

Alias
UMLS CUI [1,1]
C0677660
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0332197
UMLS CUI [2,1]
C0233514
UMLS CUI [2,2]
C0205082
UMLS CUI [2,3]
C0332197
UMLS CUI [3,1]
C1306597
UMLS CUI [3,2]
C0205082
UMLS CUI [3,3]
C0332197
UMLS CUI [4,1]
C0848067
UMLS CUI [4,2]
C0525058
UMLS CUI [4,3]
C0439801
prior concurrent therapy:
Description

Therapeutic procedure

Type de données

boolean

Alias
UMLS CUI [1]
C0087111
no concurrent participation in another investigational drug study
Description

Study Subject Participation Status Exclusion | Investigational New Drugs Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C2828389
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C0332197
Retour au début de la page

Similar models

Eligibility Lymphoma NCT00416312

1 Formulaires
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00416312
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Lymphoma, Non-Hodgkin
Item
diagnosis of non-hodgkin's lymphoma
boolean
C0024305 (UMLS CUI [1])
Measurable Disease X-Ray Computed Tomography | Measurable Disease Radionuclide Imaging
Item
measurable disease by ct scan or nuclear medicine imaging
boolean
C1513041 (UMLS CUI [1,1])
C0040405 (UMLS CUI [1,2])
C1513041 (UMLS CUI [2,1])
C0034606 (UMLS CUI [2,2])
Standard of Care criteria | Iodine-131 [I-131] tositumomab | yttrium-90-ibritumomab tiuxetan
Item
eligible, by standard of care criteria, for iodine i 131 tositumomab or yttrium y 90 ibritumomab tiuxetan treatment
boolean
C2936643 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
C1260363 (UMLS CUI [2])
C1134535 (UMLS CUI [3])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Malignant Neoplasms Absent | Basal cell carcinoma | Squamous cell carcinoma of skin | Carcinoma in situ of uterine cervix
Item
no other malignancy within the past 3 years except basal cell carcinoma or squamous cell carcinoma of the skin or in situ carcinoma of the cervix
boolean
C0006826 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0007117 (UMLS CUI [2])
C0553723 (UMLS CUI [3])
C0851140 (UMLS CUI [4])
Pregnancy Absent | Breast Feeding Absent
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Fertility Contraceptive methods
Item
fertile patients must use effective contraception
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Chronic Alcoholic Intoxication Absent | Drug abuse Absent
Item
no alcoholism or drug abuse within the past 2 years
boolean
C0001973 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0013146 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Emotional problems Severe Absent | Behaviorial problem Severe Absent | Psychiatric problem Severe Absent | Mental problem Protocol Compliance Limited
Item
no severe emotional, behavioral, or psychiatric problems that would limit study compliance
boolean
C0677660 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0233514 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C1306597 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
C0848067 (UMLS CUI [4,1])
C0525058 (UMLS CUI [4,2])
C0439801 (UMLS CUI [4,3])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Study Subject Participation Status Exclusion | Investigational New Drugs Absent
Item
no concurrent participation in another investigational drug study
boolean
C2348568 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial